Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-11-17

FDA Approved: NATACYN — Supplemental Application (Harrow Eye, LLC)

View source ↗

Summary

The FDA approved a supplemental application for NATACYN (natamycin) submitted by Harrow Eye, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NATACYN (NATAMYCIN)

Snippet

SUPPL AP for NATACYN (NATAMYCIN)